Discover 437 paid clinical trials in Rochester, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Rochester has a wide variety of active clinical trials, focusing on conditions such as kidney disease, cancer, and cardiovascular disorders. Participants in these studies have the opportunity to explore emerging treatments in the city’s leading research institutions, both as healthy volunteers in paid trials and as individuals looking for studies targeting specific health conditions.
Filter
2
Filter results
Results: 437
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Rochester NY, Webster NY, Philadelphia PA, Newark DE,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 65+
Code: NCT07321652
Phase3, Recruiting
FOCUS ON US: Adapting the FOCUS Program for Sexual and Gender Minority (SGM) Cancer Patients and Caregivers
for
Cancer Support, Oncology Patients, Caregivers
Location: Rochester NY, Detroit MI
Sponsor: Charles Kamen
Sex: All
Age: 18 - 70+
Code: NCT06800053
Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
Location: Rochester NY, New York NY, New Haven CT, Ann Arbor MI,
Sponsor: Cabaletta Bio
Sex: All
Age: 18 - 70+
Code: NCT06328777
Phase2, Phase3, Recruiting
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
for
Smoldering Multiple Myeloma
Location: Rochester NY
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT05597345
Phase2, Recruiting
A Telehealth Advance Care Planning Intervention
for
Myeloid Malignancy, Acute Myeloid Leukemia,
Location: Rochester NY
Sponsor: University of Rochester
Sex: All
Age: 60+
Code: NCT05875805
Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)